Amyotrophic Lateral Sclerosis-Parkinsonism-Dementia Complex

name: Amyotrophic Lateral Sclerosis-Parkinsonism-Dementia Complex
creation_date: "2026-06-11T00:00:00Z"
category: Complex
parents:
- Motor Neuron Disease
- Neurodegenerative Disease
disease_term:
  preferred_term: Guam amyotrophic lateral sclerosis-parkinsonism-dementia complex
  term:
    id: MONDO:0007104
    label: amyotrophic lateral sclerosis-parkinsonism-dementia complex
description: >-
  Amyotrophic lateral sclerosis-parkinsonism-dementia complex (ALS-PDC, locally
  "lytico-bodig") is a fatal, long-latency neurodegenerative disease historically
  occurring at extraordinarily high incidence in three geographically and
  ethnically distinct Western Pacific populations: the Chamorro of Guam and Rota,
  Japanese residents of the Kii Peninsula of Honshu, and the Auyu and Jakai of
  West Papua. Affected individuals develop overlapping motor neuron disease
  (ALS), atypical parkinsonism, and dementia, alone or in combination. The
  neuropathology is a multiple proteinopathy dominated by a severe Alzheimer-type
  tauopathy (neurofibrillary tangles) with accompanying TDP-43 and alpha-synuclein
  pathology. The disease is now understood to have a predominant or exclusive
  environmental origin, and its incidence has declined sharply with Westernization.
  The leading — though still contested — candidate cause is chronic dietary
  exposure to the cyanobacterial neurotoxin beta-methylamino-L-alanine (BMAA),
  biomagnified through the traditional cycad-based diet. ALS-PDC is mechanistically
  distinct from sporadic ALS and idiopathic Parkinson disease and is a touchstone
  for the environmental-toxicity model of neurodegeneration.
pathophysiology:
- name: Multiple Proteinopathy (Tau, TDP-43, and Alpha-Synuclein)
  conforms_to: "tdp43_proteinopathy#Cytoplasmic TDP-43 Aggregation"
  description: >-
    The defining neuropathology of ALS-PDC is a multiple proteinopathy. A severe,
    widely distributed Alzheimer-type neurofibrillary tau pathology dominates,
    accompanied by phosphorylated TDP-43 neuronal cytoplasmic inclusions
    (predominating in the ALS subtype and limbic system) and, in many cases,
    alpha-synuclein pathology. The shared TDP-43 component aligns ALS-PDC with the
    broader family of TDP-43 proteinopathies, while the dominant tauopathy and
    multi-protein burden distinguish it from sporadic ALS.
  role: central_effector
  cell_types:
  - preferred_term: neuron
    term:
      id: CL:0000540
      label: neuron
  biological_processes:
  - preferred_term: inclusion body assembly
    term:
      id: GO:0070841
      label: inclusion body assembly
    modifier: INCREASED
  evidence:
  - reference: PMID:29063640
    reference_title: "Amyotrophic lateral sclerosis and parkinsonism-dementia complex of the Hohara focus of the Kii Peninsula: A multiple proteinopathy?"
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Neurofibrillary tangles, including ghost tangles, and tau-positive
      astrocytes were distributed widely in all of the brains examined, and
      TDP-43-positive neuronal cytoplasmic inclusions were observed mainly in the
      limbic system.
    explanation: >-
      Autopsy series of 18 Kii ALS/PDC patients establishes the multiple
      proteinopathy: a dominant neurofibrillary tauopathy with accompanying
      TDP-43 neuronal cytoplasmic inclusions, supporting both the tau and TDP-43
      arms of this node.
  - reference: PMID:29063640
    reference_title: "Amyotrophic lateral sclerosis and parkinsonism-dementia complex of the Hohara focus of the Kii Peninsula: A multiple proteinopathy?"
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Eight patients were predominated by phosphorylated TDP-43 inclusions and
      clinically showed ALS
    explanation: >-
      In the ALS-predominant subtype, phosphorylated TDP-43 inclusions are the
      leading pathology, directly supporting conformance to the TDP-43
      proteinopathy module.
  - reference: PMID:18490618
    reference_title: "The ALS/PDC syndrome of Guam and the cycad hypothesis."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      association of the lesions with TDP-43
    explanation: >-
      Independent Guam-focused review confirms that the ALS/PDC neurofibrillary
      lesions are associated with TDP-43, corroborating the TDP-43 component
      across both the Guam and Kii foci.
  downstream:
  - target: Motor Neuron and Multisystem Neurodegeneration
    description: >-
      The tau, TDP-43, and alpha-synuclein proteinopathy drives degeneration of
      spinal and cortical motor neurons, nigral and basal-ganglia circuits, and
      limbic/cortical neurons, producing the ALS, parkinsonism, and dementia
      components of the syndrome.
- name: Cycad-Derived BMAA Excitotoxicity and Biomagnification
  conforms_to: "glutamate_excitotoxicity#Glutamate Receptor Overactivation and Calcium Overload"
  description: >-
    The leading candidate environmental mechanism is chronic dietary exposure to
    the cyanobacterial non-protein amino acid beta-methylamino-L-alanine (BMAA).
    BMAA is produced by cyanobacterial symbionts in the coralloid roots of cycad
    plants, concentrated in cycad seeds, and biomagnified up the traditional
    Chamorro food chain (cycad flour and flying foxes that forage on cycad seeds).
    Proposed neurotoxic mechanisms include glutamate-receptor (AMPA/kainate and
    NMDA/mGluR5) excitotoxicity with selective vulnerability of motor neurons,
    oxidative stress, and misincorporation into proteins in place of L-serine.
    BMAA causation remains scientifically contested (see Discussion).
  role: trigger
  cell_types:
  - preferred_term: motor neuron
    term:
      id: CL:0000100
      label: motor neuron
  biological_processes:
  - preferred_term: response to oxidative stress
    term:
      id: GO:0006979
      label: response to oxidative stress
    modifier: INCREASED
  evidence:
  - reference: PMID:28540663
    reference_title: "BMAA and Neurodegenerative Illness."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      now appears to be a cause of Guamanian amyotrophic lateral
      sclerosis/parkinsonism dementia complex (ALS/PDC)
    explanation: >-
      Frames BMAA as a candidate cause of Guam ALS/PDC acting through multiple
      neurotoxic mechanisms with selective vulnerability of motor neurons.
  - reference: PMID:14612559
    reference_title: "Biomagnification of cyanobacterial neurotoxins and neurodegenerative disease among the Chamorro people of Guam."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Free-living cyanobacteria produce 0.3 microg/g BMAA, but produce 2-37
      microg/g as symbionts in the coralloid roots of cycad trees.
    explanation: >-
      Documents the cyanobacteria-to-cycad step of BMAA biomagnification that
      underpins the dietary-exposure hypothesis for the Chamorro population.
  downstream:
  - target: Multiple Proteinopathy (Tau, TDP-43, and Alpha-Synuclein)
    description: >-
      Chronic BMAA exposure is hypothesized to seed the tau, TDP-43, and
      alpha-synuclein proteinopathy over a long latency.
- name: Motor Neuron and Multisystem Neurodegeneration
  description: >-
    The proteinopathy and candidate toxic insults converge on degeneration of
    spinal and cortical motor neurons (producing the ALS syndrome), substantia
    nigra and basal ganglia circuits (atypical, often levodopa-poor parkinsonism),
    and limbic/cortical neurons (dementia). The ALS phenotype in this population is
    notably more malignant than typical sporadic ALS.
  role: effector
  cell_types:
  - preferred_term: motor neuron
    term:
      id: CL:0000100
      label: motor neuron
  biological_processes:
  - preferred_term: neuron apoptotic process
    term:
      id: GO:0051402
      label: neuron apoptotic process
    modifier: INCREASED
  evidence:
  - reference: PMID:18490618
    reference_title: "The ALS/PDC syndrome of Guam and the cycad hypothesis."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      There is a high incidence on Guam of a severe tauopathy known as the
      Parkinson- dementia complex (PDC). It is linked with an even more malignant
      amyotrophic lateral sclerosis (ALS) syndrome.
    explanation: >-
      Establishes the clinical core of the disease: a high-incidence
      parkinsonism-dementia tauopathy linked to an especially malignant motor
      neuron disease.
environmental:
- name: Cyanobacterial BMAA and Cycad Dietary Exposure
  notes: >-
    ALS-PDC is now regarded as having a predominant or exclusive environmental
    origin, with incidence declining sharply as traditional cycad-based diets and
    lifeways were displaced by Westernization. The leading candidate exposure is
    chronic dietary BMAA biomagnified through the cycad food chain, although a
    causal role for BMAA remains contested and competing environmental hypotheses
    (trace-metal/mineral imbalance) have been proposed.
  evidence:
  - reference: PMID:27050202
    reference_title: "Seeking environmental causes of neurodegenerative disease and envisioning primary prevention."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      now known to have a predominant or exclusive environmental origin, is in
      the process of disappearing from the three heavily affected populations
    explanation: >-
      Supports the environmental etiology and the documented decline of ALS-PDC
      across all three affected Western Pacific populations.
  - reference: PMID:14612559
    reference_title: "Biomagnification of cyanobacterial neurotoxins and neurodegenerative disease among the Chamorro people of Guam."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Free-living cyanobacteria produce 0.3 microg/g BMAA, but produce 2-37
      microg/g as symbionts in the coralloid roots of cycad trees.
    explanation: >-
      Documents the biomagnification pathway central to the dietary BMAA
      exposure hypothesis.
phenotypes:
- name: Atypical Parkinsonism
  phenotype_term:
    preferred_term: Parkinsonism
    term:
      id: HP:0001300
      label: Parkinsonism
  evidence:
  - reference: PMID:18490618
    reference_title: "The ALS/PDC syndrome of Guam and the cycad hypothesis."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      There is a high incidence on Guam of a severe tauopathy known as the
      Parkinson- dementia complex (PDC).
    explanation: >-
      The parkinsonism-dementia complex component is defined by atypical
      parkinsonism on a tauopathy background.
- name: Dementia
  phenotype_term:
    preferred_term: Dementia
    term:
      id: HP:0000726
      label: Dementia
  evidence:
  - reference: PMID:18490618
    reference_title: "The ALS/PDC syndrome of Guam and the cycad hypothesis."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      There is a high incidence on Guam of a severe tauopathy known as the
      Parkinson- dementia complex (PDC).
    explanation: >-
      Dementia is a defining clinical feature of the parkinsonism-dementia
      complex.
- name: Motor Neuron Disease (ALS)
  phenotype_term:
    preferred_term: Amyotrophic lateral sclerosis
    term:
      id: HP:0007354
      label: Amyotrophic lateral sclerosis
  evidence:
  - reference: PMID:18490618
    reference_title: "The ALS/PDC syndrome of Guam and the cycad hypothesis."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      It is linked with an even more malignant amyotrophic lateral sclerosis
      (ALS) syndrome.
    explanation: >-
      A severe motor neuron disease (ALS) is a core component of the complex.
discussions:
- discussion_id: gap_alspdc_bmaa_human_model_mismatch
  prompt: >-
    Do the primate (vervet) and rodent BMAA models, which reproduce ALS-PDC-like
    neurofibrillary tau, beta-amyloid, and TDP-43 pathology after dietary or
    parenteral BMAA, faithfully establish BMAA as a cause of human Guam ALS-PDC —
    or does the unresolved analytical detection of BMAA in human brain and the
    failure of some laboratories to replicate it mean that translational validity
    to the human Chamorro disease remains the open question?
  kind: HUMAN_MODEL_MISMATCH
  status: OPEN
  attaches_to:
  - pathophysiology#Cycad-Derived BMAA Excitotoxicity and Biomagnification
  - pathophysiology#Multiple Proteinopathy (Tau, TDP-43, and Alpha-Synuclein)
  rationale: >-
    Chronic dietary BMAA in vervets reproduces neurofibrillary tangles and
    beta-amyloid deposits structurally similar to those in Chamorros who died of
    ALS-PDC, and L-serine co-administration reduces tangle density — strong
    experimental support for the hypothesis. However, a U.S. EPA-led critical
    review concluded that the existing data do not support a causal BMAA-disease
    relationship, and brain-BMAA detection is method-dependent with documented
    replication failures. The mismatch is mechanistically meaningful because the
    animal models supply the principal causal evidence, while the human evidence
    rests on contested analytical chemistry; resolving it requires
    method-harmonized human measurement rather than further model recapitulation.
  proposed_experiments:
  - experiment_id: exp_alspdc_bmaa_harmonized_human_brain
    name: Method-harmonized quantification of brain BMAA in ALS-PDC versus controls
    description: >-
      Conduct a multi-laboratory, blinded, orthogonal-method (LC-MS/MS with
      derivatization plus underivatized HILIC) quantification of free and
      protein-bound BMAA in banked ALS-PDC, sporadic ALS, Alzheimer disease, and
      neurologically normal control brains, with pre-registered detection
      thresholds, to determine whether brain BMAA is reproducibly elevated in
      ALS-PDC across methods and laboratories.
    experiment_type:
      preferred_term: analytical neurochemistry case-control study
    model_systems:
    - name: Human postmortem brain tissue cohort
      description: >-
        Banked human brain specimens from ALS-PDC, disease-control, and normal
        cases analyzed for BMAA by harmonized orthogonal analytical methods.
      experimental_model_type: OTHER
  evidence:
  - reference: PMID:26791617
    reference_title: "Dietary exposure to an environmental toxin triggers neurofibrillary tangles and amyloid deposits in the brain."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      similar in structure and density to those found in brain tissues of
      Chamorros who died with ALS/PDC
    explanation: >-
      The vervet model is the strongest experimental support that dietary BMAA
      can recapitulate ALS-PDC neuropathology — but as model-organism evidence it
      cannot by itself establish human causation.
  - reference: PMID:28598725
    reference_title: "A critical review of the postulated role of the non-essential amino acid, beta-N-methylamino-L-alanine, in neurodegenerative disease in humans."
    supports: REFUTE
    evidence_source: OTHER
    snippet: >-
      is not supported by existing data
    explanation: >-
      The EPA-led critical review concludes that a causal BMAA-neurodegenerative
      disease relationship in humans is not supported by existing data,
      articulating the skeptical pole of the controversy.